Identification of novel inhibitors of tetranectin–plasminogen interaction to suppress breast cancer invasion: an integrated computational and cell-based investigation

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Adasme, M. F., Linnemann, K. L., Bolz, S. N., Kaiser, F., Salentin, S., Haupt, V. J., & Schroeder, M. (2021). PLIP 2021: Expanding the scope of the protein–ligand interaction profiler to DNA and RNA. Nucleic Acids Research, 49(W1), W530–W534.
   PubMed Web of Science ®Google Scholar
• Amin, A., Chikan, N. A., Mokhdomi, T. A., Bukhari, S., Koul, A. M., Shah, B. A., Gharemirshamlu, F. R., Wafai, A. H., Qadri, A., & Qadri, R. A. (2016). Irigenin, a novel lead from Western Himalayan chemiome inhibits Fibronectin-Extra Domain A induced metastasis in Lung cancer cells. Scientific Reports, 6(1), 1–13. https://doi.org/10.1038/srep37151
   PubMedGoogle Scholar
• Amin, A., Mokhdomi, T. A., Bukhari, S., Wani, Z., Chikan, N. A., Shah, B. A., Koul, A. M., Majeed, U., Farooq, F., & Qadri, A. (2021). Lung cancer cell‐derived EDA‐containing fibronectin induces an inflammatory response from monocytes and promotes metastatic tumor microenvironment. Journal of Cellular Biochemistry, 122(5), 562–576. https://doi.org/10.1002/jcb.29883
   PubMed Web of Science ®Google Scholar
• Amin, A., Mokhdomi, T. A., Bukhari, S., Wani, S. H., Wafai, A. H., Lone, G. N., Qadri, A., & Qadri, R. A. (2015). Tectorigenin ablates the inflammation-induced epithelial–mesenchymal transition in a co-culture model of human lung carcinoma. Pharmacological Reports : PR, 67(2), 382–387. https://doi.org/10.1016/j.pharep.2014.10.020
   PubMed Web of Science ®Google Scholar
• Berglund, L., & Petersen, T. E. (1992). The gene structure of tetranectin, a plasminogen binding protein. FEBS Letters, 309(1), 15–19. https://doi.org/10.1016/0014-5793(92)80729-Z
   PubMed Web of Science ®Google Scholar
• Chen, H., Li, H., Zhao, J., Peng, P., Shao, M., Wu, H., Wang, X., Chen, L., Zhang, Q., & Ruan, Y. (2017). High intratumoral expression of tetranectin associates with poor prognosis of patients with gastric cancer after gastrectomy. Journal of Cancer, 8(17), 3623. https://doi.org/10.7150/jca.19438
   PubMed Web of Science ®Google Scholar
• Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012). admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. Journal of Chemical Information and Modeling, 52(11), 3099–3105.
   Google Scholar
• Chiang, C.-T., Way, T.-D., Tsai, S.-J., & Lin, J.-K. (2007). Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation. FEBS Letters, 581(30), 5735–5742. https://doi.org/10.1016/j.febslet.2007.11.021
   PubMed Web of Science ®Google Scholar
• Christensen, L., & Clemmensen, I. (1991). Differences in tetranectin immunoreactivity between benign and malignant breast tissue. Histochemistry, 95(5), 427–433.
   PubMedGoogle Scholar
• Daina, A., Michielin, O., & Zoete, V. J. S. r (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 1–13.
   Google Scholar
• DE Vries, T. J., DE Wit, P. E., Clemmensen, I., Verspaget, H. W., Weidle, U. H., BROeCKER, E. B., Ruiter, D. J., & VAN Muijen, G. N. (1996). Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesions. The Journal of Pathology, 179(3), 260–265.
   PubMed Web of Science ®Google Scholar
• Eberhardt, J., Santos-Martins, D., Tillack, A. F., & Forli, S. (2021). AutoDock Vina 1.2. 0: New docking methods, expanded force field, and python bindings. Journal of Chemical Information and Modeling, 61(8), 3891–3898.
   PubMed Web of Science ®Google Scholar
• El Bairi, K., Ouzir, M., Agnieszka, N., & Khalki, L. (2017). Anticancer potential of Trigonella foenum graecum: cellular and molecular targets. Biomedicine & Pharmacotherapy, 90, 479–491.
   PubMed Web of Science ®Google Scholar
• Fuentes-Tristan, S., Parra-Saldivar, R., Iqbal, H. M., & Carrillo-Nieves, D. (2019). Bioinspired biomolecules: Mycosporine-like amino acids and scytonemin from Lyngbya sp. with UV-protection potentialities. Journal of Photochemistry and Photobiology B: Biology, 201, 111684.
   PubMed Web of Science ®Google Scholar
• Graversen, J. H., Lorentsen, R. H., Jacobsen, C., Moestrup, S. K., Sigurskjold, B. W., Thøgersen, H. C., & Etzerodt, M. (1998). The plasminogen binding site of the C-type lectin tetranectin is located in the carbohydrate recognition domain, and binding is sensitive to both calcium and lysine. The Journal of Biological Chemistry, 273(44), 29241–29246. https://doi.org/10.1074/jbc.273.44.29241
   PubMed Web of Science ®Google Scholar
• Høgdall, C., Christensen, L., & Clemmensen, I. (1994). Tetranectin, a plasma and tissue protein–a prognostic marker of breast and ovarian cancer. Ugeskrift for Laeger, 156(42), 6190–6195.
   PubMedGoogle Scholar
• Høgdall, C. K., Christensen, L., & Clemmensen, I. (1993). The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer. Cancer, 72(8), 2415–2422.
   PubMed Web of Science ®Google Scholar
• Høgdall, C. K., Hørding, U., Nørgaard-Pedersen, B., Toftager-Larsen, K., & Clemmensen, I. (1994). Serum tetranectin and CA-125 used to monitor the course of treatment in ovarian cancer patients. European Journal of Obstetrics & Gynecology and Reproductive Biology, 57(3), 175–178.
   PubMed Web of Science ®Google Scholar
• Høgdall, C. K., Mogensen, O., Tabor, A., Mogensen, B., Jakobsen, A. K., Nørgaard-Pedersen, B., Larsen, S. O., & Clemmensen, I. (1995). The role of serum tetranectin, CA 125, and a combined index as tumor markers in women with pelvic tumors. Gynecologic Oncology, 56(1), 22–28.
   PubMed Web of Science ®Google Scholar
• Holtet, T. L., Graversen, J. H., Thøgersen, H. C., Etzerodt, M., & Clemmensen, I. (1997). Tetranectin, a trimeric plasminogen‐binding C‐type lectin. Protein Science, 6(7), 1511–1515.
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. J. J. M. G. (1996). VMD: visual molecular dynamics. Journal of molecular graphics, 14, 33–38.
   Google Scholar
• Kumari, R., Kumar, R., Consortium, O. S. D. D., & Lynn, A. (2014). g_mmpbsa—A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962.
   PubMed Web of Science ®Google Scholar
• Li, F., Fernandez, P. P., Rajendran, P., Hui, K. M., & Sethi, G. (2010). Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Letters, 292(2), 197–207.
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A. J. D. d t T. (2004). Lead-and drug-like compounds: the rule-of-five revolution. Drug discovery today: Technologies, 1(4), 337–341.
   Google Scholar
• Moalic, S., Liagre, B., Corbière, C., Bianchi, A., Dauça, M., Bordji, K., & Beneytout, J. L. (2001). A plant steroid, diosgenin, induces apoptosis, cell cycle arrest and COX activity in osteosarcoma cells. FEBS Letters, 506(3), 225–230.
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791.
   PubMed Web of Science ®Google Scholar
• Newman, D. J., & Cragg, G. M. (2016). Natural products as sources of new drugs from 1981 to 2014. Journal of Natural Products, 79(3), 629–661.
   PubMed Web of Science ®Google Scholar
• Nielsen, B. B., Kastrup, J. S., Rasmussen, H., Holtet, T. L., Graversen, J. H., Etzerodt, M., Thøgersen, H. C., & Larsen, I. K. (1997). Crystal structure of tetranectin, a trimeric plasminogen-binding protein with an α-helical coiled coil. FEBS Letters, 412(2), 388–396. https://doi.org/10.1016/s0014-5793(97)00664-9
   PubMed Web of Science ®Google Scholar
• Obrist, P., Spizzo, G., Ensinger, C., Fong, D., Brunhuber, T., Schäfer, G., Varga, M., Margreiter, R., Amberger, A., & Gastl, G. (2004). Aberrant tetranectin expression in human breast carcinomas as a predictor of survival. Journal of Clinical Pathology, 57(4), 417–421.
   PubMed Web of Science ®Google Scholar
• Romero-Hernandez, L. L., Merino-Montiel, P., Montiel-Smith, S., Meza-Reyes, S., Vega-Báez, J. L., Abasolo, I., Schwartz, S., Jr, Lopez, O., & Fernandez-Bolanos, J. G. (2015). Diosgenin-based thio (seleno) ureas and triazolyl glycoconjugates as hybrid drugs. Antioxidant and antiproliferative profile. European Journal of Medicinal Chemistry, 99, 67–81.
   PubMed Web of Science ®Google Scholar
• Salsbury Jr, F. R. (2010). Molecular dynamics simulations of protein dynamics and their relevance to drug discovery. Current Opinion in Pharmacology, 10(6), 738–744.
   Google Scholar
• Schüttelkopf, A. W., & Van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallographica Section D: Biological Crystallography, 60(8), 1355–1363.
   PubMedGoogle Scholar
• Shanmugam, M. K., Warrier, S., Kumar, A. P., Sethi, G., & Arfuso, F. (2017). Potential role of natural compounds as anti-angiogenic agents in cancer. Current Vascular Pharmacology, 15(6), 503–519.
   PubMed Web of Science ®Google Scholar
• Verspaget, H., Clemmensen, I., Ganesh, S., Christensen, L., Sier, C., Griffioen, G., & Lamers, C. (1994). Tetranectin expression in human colonic neoplasia. Histopathology, 25(5), 463–467.
   PubMed Web of Science ®Google Scholar
• Wewer, U., & Albrechtsen, R. (1992). Tetranectin, a plasminogen kringle 4-binding protein. Cloning and gene expression pattern in human colon cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology, 67(2), 253–262.
   PubMed Web of Science ®Google Scholar
• Yang, H., Lou, C., Sun, L., Li, J., Cai, Y., Wang, Z., Li, W., Liu, G., & Tang, Y. J. B. (2019). admetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties. Bioinformatics, 35(6), 1067–1069.
   Google Scholar